EP Patent

EP2563341A1 — Pharmaceutical compositions inducing synergistic effect

Assigned to Individual · Expires 2013-03-06 · 13y expired

What this patent protects

The present invention relates to a pharmaceutical composition comprising dexlansoprazole and domperidone and use of said composition in the treatment of acid-related gastrointestinal disturbances, particularly in the treatment of diseases related with gastroesophageal reflux.

USPTO Abstract

The present invention relates to a pharmaceutical composition comprising dexlansoprazole and domperidone and use of said composition in the treatment of acid-related gastrointestinal disturbances, particularly in the treatment of diseases related with gastroesophageal reflux.

Drugs covered by this patent

Prevacid (lansoprazole) · Generic (originally Takeda)

Patent Metadata

Patent number: EP2563341A1
Jurisdiction: EP
Classification: —
Expires: 2013-03-06
Drug substance claim: No
Drug product claim: No
Assignee: Individual
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.